The latest ceasefire between Israel and Hizbollah, along with a pullback in Brent crude to $79.25 a barrel and a planned reopening of the Strait of Hormuz, has quickly reshaped expectations around geopolitical risk and energy supply. For emerging markets equities, that mix of lower immediate tension and lingering uncertainty can shift how investors think about risk, pricing power, and capital flows. This article looks at 3 stocks from an Emerging Markets Equities screener that appear positively exposed to this news and may deserve a closer look in your own research process.

BrainsWay (TASE:BWAY)

Overview: BrainsWay is a Jerusalem based medical technology company that develops and sells Deep Transcranial Magnetic Stimulation systems, which are noninvasive devices used by psychiatrists and hospitals to treat a wide range of mental health and neurological conditions, including depression, OCD, smoking addiction and several other brain related disorders.

Operations: BrainsWay currently generates approximately US$56.22 million in revenue from the development and commercialization of its Deep TMS system.

Market Cap: ₪1.69b

BrainsWay stands out in this screener because it combines exposure to Israel’s improved risk sentiment with a growing mental health treatment franchise built around its Deep TMS technology. This is supported by 15.6% net margins and a multi year record of profitability. Recent clinical data on its SWIFT protocol for major depressive disorder, including sustained 12 month benefits, points to a product that doctors may keep using once it is installed. Q1 2026 results show higher revenue and earnings alongside guidance that targets double digit operating margins. The trade off is a rich P/E multiple and a share price that screens as expensive relative to estimated cash flows, so the key question is whether that growth and clinical momentum can justify a premium valuation.

BrainsWay’s profitability and premium P/E suggest the market senses something bigger is building, yet the current pricing still leaves key questions open. Study the DCF valuation analysis for BrainsWay to see what the headline multiple might be missing.

Beltone HoldingE (CASE:BTFH)

Overview: Beltone HoldingE is an Egypt based financial services group that offers a wide mix of non banking financial services, investment banking, brokerage, asset management, research, electronic payments, HR outsourcing, data analytics, real estate brokerage, and SME focused solutions across the MENA region.

Market Cap: EGP32.26b

Beltone HoldingE gives you exposure to a broad financial services ecosystem at a time when Egyptian and wider North African equities may be influenced by reduced regional risk and more reliable trade routes after the latest ceasefire and the planned reopening of key shipping channels. Revenue of EGP 13,221.51 million and net profit margins of 19.4% sit alongside forecasts for around 34% annual growth in both earnings and revenue, but the relatively high 23.9x P/E and reliance on higher risk external borrowing instead of customer deposits raise clear questions about resilience if conditions tighten. With profitability established over the past five years and governance that is evolving, the central issue is whether the growth outlook can justify current pricing as sentiment toward the region changes.

Rapid earnings and revenue forecasts alongside a 23.9x P/E suggest Beltone HoldingE’s story is still being priced in, but the real tension sits inside the analyst forecasts for Beltone HoldingE that could reveal what the headline numbers are not telling investors yet

Almoosa Health (SASE:4018)

Overview: Almoosa Health is a Saudi private healthcare provider that runs specialist and rehabilitation hospitals, clinics, pharmacies, oncology and mental health centers, and a college of health sciences, as well as distributing medicines, cosmetics, and disposable medical items across a wide range of medical specialties.

Operations: Almoosa Health generates about SAR 1.44b in revenue, primarily from Medical Services (SAR 922.1m), Pharmaceuticals (SAR 321.9m), and Rehabilitation (SAR 197.6m), all within Saudi Arabia.

Market Cap: SAR5.45b

Almoosa Health provides direct exposure to Saudi healthcare demand, with a broad hospital and clinic footprint. The company recently reported a net margin of about 13.4%. At the same time, it is in an expansion J curve, with margin pressure from newly opened centers and a high debt load that depends on external borrowing rather than customer deposits. With the stock trading below some fair value estimates and benefiting from reduced regional tension after the latest ceasefire, the key question is whether the combination of its strategic growth initiatives and Vision 2030 dynamics adequately offsets its premium P/E and funding risks, and what that means for future returns as new capacity fills.

Almoosa Health’s expansion J curve, solid net margin and debt funded growth story could be masking a key twist in its outlook, and the analyst forecasts for Almoosa Health might be where that twist finally becomes clear

The three stocks here are just a starting point, and the full Emerging Markets Equities screener surfaced 9 more companies with equally compelling risk, return, and geopolitical narratives that could add real depth to your watchlist, so it is worth reviewing the full Emerging Markets Equities screener. By using Simply Wall St, you can quickly identify and analyze the specific catalysts, balance sheet profiles, and regional exposures discussed in this article, allowing you to focus on the highest conviction emerging markets ideas for your own portfolio research.

Take Control of Your Investment Journey

If Beltone HoldingE or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Alternatives Before Momentum Flies Past?

Fresh ideas can move first, and the best setups are often caught before momentum is obvious. While it matters and is still under the radar for now, act now.

• Spot resilient income as you review 497 dividend fortresses built around companies that aim to keep paying investors even when other stocks are dropping or losing momentum.
• Track the backbone of AI progress through 49 AI infrastructure stocks where critical suppliers and enablers could see demand build long before the crowd catches on.
• Chase early leadership in industrial transformation with 31 robotics and automation stocks focused on companies automating factories, warehouses and logistics routes while the theme is still flying under most radars.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.